Research Partnerships
Genolux collaborates with pharmaceutical and biotech research teams on PPI target characterization and computational hit discovery engagements.
Three Ways to Work with Genolux
Target Characterization Study
Genolux characterizes a specific PPI complex from your pipeline — hot-spot mapping, pocket geometry, initial virtual screen. Fixed-scope engagement delivered in 4–8 weeks. Deliverables include a structural report, ranked hit list, and SAR hypotheses.
Platform License
Annual access to the full Genolux platform — API, web interface, PPI complex library, and fragment screening. For discovery teams running multiple PPI programs who want direct, iterative access to the scoring engine.
Research Collaboration
Joint research program with co-publication rights and data sharing. For academic partners and early-stage biotechs exploring novel PPI targets. Project scope and IP terms negotiated on a case-by-case basis.
Interested in a Partnership?
Contact Dr. Elena Voss directly to discuss what Genolux can contribute to your PPI discovery program.
Start the Conversation